Tag Archives: Circulating tumour DNA

Pancreatic cancer is a disease that carries a poor prognosis. Accurate tissue diagnosis is required. Tumours contain a high content of stromal tissue and therefore biopsies may be inconclusive. Circulating tumour cells (CTCs) have been investigated as a potential “liquid ...

Part of Molecular Diagnostics Europe – 4-7 April, 2016, Sheraton Lisboa, Lisbon, Portugal Circulating tumour DNA has grown in popularity given its ability to detect minimal residual disease and monitor treatment. Regardless of growing proof of its utility, much needs ...